Donanemab, a new drug for early Alzheimer’s, significantly slowed progression of the disease in clinical trial results. Learn more about the treatment.| Alzheimer’s Association
MCI can progress to dementia, but it often doesn’t.| UNC Health Talk
Alzheimer's typically progresses in three stages: early, middle and late (mild, moderate and severe). Learn about dementia symptoms to expect at each stage.| Alzheimer’s Association